Test Overview
Test Methodology

Sure-Vue - rapid chromatographic immunoassay

Test Usage

Performed in the Emergency room laboratories by authorized laboratory personnel. Human Chorionic Gonadotropin (hCG) detection is most often used to confirm pregnancy.

Reference Range *

Negative results are expected in healthy non-pregnant women and healthy men.

Test Limitations

False negative results may occur when the levels of hCG are below the sensitivity level of the test. Diluted urine specimens with low specific gravity may not contain enough hCG for detection. If pregnancy is still suspected, a first morning specimen should be obtained. A number of conditions other than pregnancy, including trophoblastic disease, and certain nontrophoblastic neoplams; including testicular tumors, prostate tumors, breast cancer and lung cancer cause elevated level of hCG. This test reliably detects intact hCG up to 5000,000 mIU/mL. It does not reliably detect hCG degradation products, including free-beta hCG and beta core fragments. Quantitative assays used to detect hCG may detect hCG degradation products and therefore may disagree with the results of this rapid test. This test provides a presumptive diagnosis for pregnancy. A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.

Test Details
Days Set Up
Continous
Analytic Time

4 minutes

Soft Order Code
EPRGU
MiChart Code
Urine Pregnancy, ED, Point of Care
Laboratory
Chemical Pathology
Section
Automation
Specimen Requirements
Collection

Urine only

Collection Instructions

N/A

Normal Volume
15 mL
Minimum Volume
1 mL
Billing
CPT Code
81025
LOINC
2106-3
NY State Approved
No